MedCap AB (publ) - Asset Resilience Ratio

Latest as of December 2025: 14.21%

MedCap AB (publ) (MCAP) has an Asset Resilience Ratio of 14.21% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr370.40 Million

≈ $39.86 Million USD Cash + Short-term Investments

Total Assets

Skr2.61 Billion

≈ $280.45 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how MedCap AB (publ)'s Asset Resilience Ratio has changed over time. Check MedCap AB (publ) PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down MedCap AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MedCap AB (publ) market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr370.40 Million	14.21%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr370.40 Million	14.21%

Asset Resilience Insights

Moderate Liquidity: MedCap AB (publ) has 14.21% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

MedCap AB (publ) Industry Peers by Asset Resilience Ratio

Compare MedCap AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Bio-Rad Laboratories Inc NYSE:BIO	Medical Devices	10.80%
Double Medical Technology Inc SHE:002901	Medical Devices	12.59%
Tellgen Corp SHE:300642	Medical Devices	9.96%
Affluent Medical SAS PA:AFME	Medical Devices	0.03%
Cochlear Ltd AU:COH	Medical Devices	9.76%
Anteris Technologies Global Corp AU:AVR	Medical Devices	33.27%
Imricor Medical Systems Inc AU:IMR	Medical Devices	46.50%
Polynovo Ltd AU:PNV	Medical Devices	0.04%

Annual Asset Resilience Ratio for MedCap AB (publ) (2016–2025)

The table below shows the annual Asset Resilience Ratio data for MedCap AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	14.21%	Skr370.40 Million ≈ $39.86 Million	Skr2.61 Billion ≈ $280.45 Million	-4.37pp
2024-12-31	18.58%	Skr370.10 Million ≈ $39.83 Million	Skr1.99 Billion ≈ $214.31 Million	+7.26pp
2023-12-31	11.32%	Skr188.20 Million ≈ $20.25 Million	Skr1.66 Billion ≈ $178.88 Million	-5.20pp
2022-12-31	16.53%	Skr236.20 Million ≈ $25.42 Million	Skr1.43 Billion ≈ $153.82 Million	+4.58pp
2021-12-31	11.95%	Skr139.70 Million ≈ $15.03 Million	Skr1.17 Billion ≈ $125.86 Million	-1.60pp
2020-12-31	13.55%	Skr146.50 Million ≈ $15.77 Million	Skr1.08 Billion ≈ $116.37 Million	+11.10pp
2019-12-31	2.45%	Skr20.60 Million ≈ $2.22 Million	Skr842.30 Million ≈ $90.64 Million	+0.23pp
2018-12-31	2.21%	Skr14.80 Million ≈ $1.59 Million	Skr668.90 Million ≈ $71.98 Million	-8.01pp
2017-12-31	10.22%	Skr61.33 Million ≈ $6.60 Million	Skr600.20 Million ≈ $64.59 Million	+2.66pp
2016-12-31	7.56%	Skr42.59 Million ≈ $4.58 Million	Skr563.16 Million ≈ $60.61 Million	--

pp = percentage points

About MedCap AB (publ)

ST:MCAP Sweden Medical Devices

Market Cap

$886.54 Million

Skr8.24 Billion SEK

Market Cap Rank

#9261 Global

#147 in Sweden

Share Price

Skr548.50

Change (1 day)

-0.54%

52-Week Range

Skr453.00 - Skr670.00

All Time High

Skr670.00